Edition:
United States

Corium International Inc (CORI.OQ)

CORI.OQ on NASDAQ Stock Exchange Global Market

11.43USD
17 Nov 2017
Change (% chg)

$0.74 (+6.92%)
Prev Close
$10.69
Open
$11.08
Day's High
$11.62
Day's Low
$10.69
Volume
171,523
Avg. Vol
55,610
52-wk High
$11.62
52-wk Low
$2.73

Latest Key Developments (Source: Significant Developments)

Corium reports Q4 loss per share $0.36
Thursday, 16 Nov 2017 04:02pm EST 

Nov 16 (Reuters) - Corium International Inc :Corium reports fourth quarter and fiscal year 2017 financial results and corporate highlights.Q4 loss per share $0.36.Q4 revenue $9.4 million versus I/B/E/S view $9.5 million.Q4 earnings per share view $-0.40 -- Thomson Reuters I/B/E/S.Corium International Inc - ‍Cash and cash equivalents as of September 30, 2017 were $57.5 million​.  Full Article

Corium Q3 loss per share $0.43
Thursday, 3 Aug 2017 04:02pm EDT 

Aug 3 (Reuters) - Corium International Inc :Corium reports recent corporate highlights and financial results for third quarter fiscal 2017.Q3 loss per share $0.43.Q3 revenue $8.1 million versus I/B/E/S view $9.1 million.Q3 earnings per share view $-0.32 -- Thomson Reuters I/B/E/S.Corium International Inc - ‍cash and cash equivalents as of June 30, 2017 were $66.6 million​.  Full Article

Broadfin Capital reports passive stake of 12.74 pct in Corium International
Thursday, 25 May 2017 05:45pm EDT 

May 25 (Reuters) - Corium International Inc :Broadfin capital llc reports a passive stake of 12.74 percent in corium international as of may 25 - sec filing.Broadfin capital llc earlier reported a passive stake of 8.53 percent in corium international as of dec 31 2016 - sec filing.  Full Article

Corium prices follow-on offering of common stock
Thursday, 25 May 2017 08:30am EDT 

May 25 (Reuters) - Corium International Inc :Corium prices follow-on offering of common stock.Pricing of its underwritten public offering of 5.6 million shares of common stock at a public offering price of $6.25/share.  Full Article

Corium reports positive preliminary results in Alzheimer’s clinical study
Thursday, 11 May 2017 07:02am EDT 

May 11 (Reuters) - Corium International Inc :Corium reports positive preliminary results in Alzheimer's clinical study.Corium International Inc reports preliminary positive results from its recently completed pilot bioequivalence (BE) study.Corium International - planning to start pivotal be study later this year, on track to file a section 505(b)(2) NDA for product candidate in 2018.  Full Article

Corium International reports Q2 loss per share $0.42
Thursday, 11 May 2017 07:00am EDT 

May 11 (Reuters) - Corium International Inc :Corium reports second quarter fiscal 2017 financial results and recent corporate highlights.Q2 loss per share $0.42.Q2 revenue $7.3 million versus i/b/e/s view $6.4 million.Q2 earnings per share view $-0.37 -- Thomson Reuters I/B/E/S.Expects to initiate pivotal bioequivalence study this fall, with preliminary topline results expected in February 2018.Targeting submission of a section 505(B)(2) new drug application (NDA) in second half of 2018.Corium international and P&G entered into new commercial supply agreement that among other things,extends term of supply relationship to March 31,2022.Cash and cash equivalents as of March 31, 2017 were $40.6 million.  Full Article

RTW Investments reports 5 pct passive stake in Corium International
Friday, 5 May 2017 05:42pm EDT 

May 5 (Reuters) - RTW Investments Lp::RTW Investments Lp reports a 5 percent passive stake in Corium International Inc as of May 1 - SEC filing.  Full Article

Corium International says entered supply agreement with Procter & Gamble Manufacturing Co
Monday, 1 May 2017 07:22am EDT 

May 1 (Reuters) - Corium International Inc ::Corium International Inc - on April 25, co and Procter & Gamble Manufacturing Company entered into commercial supply agreement effective May 1, 2017.Corium International Inc - pursuant to supply agreement, company will continue to produce and supply to p&g oral care products.Corium International Inc - supply agreement will remain in effect until march 31, 2022, absent early termination for material uncured breach.  Full Article

Corium reports Q1 loss per share $0.46
Monday, 13 Feb 2017 04:02pm EST 

Corium International Inc : Corium reports first quarter fiscal 2017 financial results . Q1 loss per share $0.46 . Q1 revenue $7.0 million versus I/B/E/S view $8.1 million .Q1 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S.  Full Article

Corium prices follow-on offering of common stock
Thursday, 2 Feb 2017 08:30am EST 

Corium International Inc : Says public offering of 6.67 million common shares priced at $3.00per share . Corium prices follow-on offering of common stock .Corium international inc- to use net proceeds for product development and general corporate purposes, which may include reducing indebtedness.  Full Article

BRIEF-Corium reports Q4 loss per share $0.36

* Corium reports fourth quarter and fiscal year 2017 financial results and corporate highlights